CÁNCER DE PRÓSTATA OLIGOMETASTÁSICO: El papel de la radioterapia - page 36

• 22p dx OligoMet Ca Próstata (55% 1 met)  Tto Ht+RT (65Gy) IMRT-3D-Dinámica.
- 18F-Choline o C11-Acetate PET-CT.
- Rec. ganglionar local: 9 RGDistal:6 Óseas:6 Visceral: 1.
- 39m seguimiento (11-75m):
-3 años SLRBq 63% SG 89%.
-La variable asociada a SLRBq es la edad>61ª.
• Proponen un ensayo con Htcorta duración+RTAltas dosis vs HT intermitente.
A Limited Course Of Androgen Deprivation And High Dose Targeted Radiotherapy Of Regional And/or Distant Oligometastatic Recurrences May Prolong Biochemical Free
Survival In Prostate Cancer Patients. IJROBP Vol. 81, Issue 2, Supplement, Pages S445-S446
Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases.
Schick U, Jorcano S, Nouet P, Rouzaud M, Vees H, Zilli T, Ratib O, Weber DC, Miralbell R. Acta Oncol. 2013 Nov;52(8):1622-8. Epub 2013 Apr 2.